Immunovant (IMVT) Assets (2018 - 2026)
Immunovant (IMVT) posted Assets of $852.49 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 28.9% from $661.44 million a year earlier but down 10.9% from the prior quarter.
Immunovant (IMVT) Assets (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant's Assets came in at $957.01 million, up 23.3% from FY2025.
- Annual Assets has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 18.3% (FY2021 to FY2026).
- In prior fiscal years, Immunovant's Assets was $776.22 million in FY2025 (+16.5%), $666.37 million in FY2024 (+64.2%), $405.84 million in FY2023 (-21.3%) and $515.56 million in FY2022 (+25.0%).
- Quarterly Assets has run from a low of $292.07 million in fiscal Q2 2024 to a high of $1.05 billion in fiscal Q3 2026 over five years.
- On a year-over-year basis, Assets has increased in each of the last six quarters, with growth averaging 35.0% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was fiscal Q3 2026, with growth of 150.0%; the weakest was fiscal Q3 2025, with a decline of 40.8%.
- According to Business Quant data, Assets for the three prior fiscal quarters was $957.01 million (Q4 2026), $1.05 billion (Q3 2026) and $582.96 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - | 852.49 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 852.49 Mn |
| Mar 31, 2026 | 957.01 Mn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 582.96 Mn |
| Jun 30, 2025 | 661.44 Mn |
| Mar 31, 2025 | 776.22 Mn |
| Dec 31, 2024 | 420.93 Mn |
| Sep 30, 2024 | 515.71 Mn |
| Jun 30, 2024 | 589.68 Mn |
| Mar 31, 2024 | 666.37 Mn |
| Dec 31, 2023 | 711.45 Mn |
| Sep 30, 2023 | 292.07 Mn |
| Jun 30, 2023 | 351.22 Mn |
| Mar 31, 2023 | 405.84 Mn |
| Dec 31, 2022 | 456.24 Mn |
| Sep 30, 2022 | 428.15 Mn |
| Jun 30, 2022 | 458.66 Mn |
| Mar 31, 2022 | 515.56 Mn |
| Dec 31, 2021 | 543.18 Mn |
| Sep 30, 2021 | 566.73 Mn |
Immunovant Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IMVT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();